Cell Therapy Manufacturing Takes Shape Across Asia-Pacific
Cell and gene therapy is accelerating across Asia-Pacific, but manufacturing remains fragmented. Strategic automation, adaptable bioprocessing platforms, stronger supply chains, and workforce development could help therapies scale across diverse markets.